OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 909-923
Open Access | Times Cited: 15
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 909-923
Open Access | Times Cited: 15
Showing 15 citing articles:
Current Trends and Impact of Liver Biopsy on Survival in Hepatocellular Carcinoma: A Korean Multicenter Analysis
Seong Joon Chun, Jeong‐Ju Yoo, Sang Gyune Kim, et al.
Diagnostics (2025) Vol. 15, Iss. 7, pp. 818-818
Open Access
Seong Joon Chun, Jeong‐Ju Yoo, Sang Gyune Kim, et al.
Diagnostics (2025) Vol. 15, Iss. 7, pp. 818-818
Open Access
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Sheng Zhong, Fengtao Zhang, Haiming Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 445-458
Closed Access
Sheng Zhong, Fengtao Zhang, Haiming Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 445-458
Closed Access
Hepatocellular Carcinoma: Advances in Systemic Therapy
Insija Ilyas Selene, Merve Özen, Reema Patel
Seminars in Interventional Radiology (2024) Vol. 41, Iss. 01, pp. 056-062
Closed Access | Times Cited: 3
Insija Ilyas Selene, Merve Özen, Reema Patel
Seminars in Interventional Radiology (2024) Vol. 41, Iss. 01, pp. 056-062
Closed Access | Times Cited: 3
Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
YiFeng Liang, L M Gan, DeJin Zeng, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2652-2664
Closed Access | Times Cited: 3
YiFeng Liang, L M Gan, DeJin Zeng, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2652-2664
Closed Access | Times Cited: 3
Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells
Zengbin Wang, Linqing Wu, Yu Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Zengbin Wang, Linqing Wu, Yu Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 807-823
Open Access | Times Cited: 3
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 807-823
Open Access | Times Cited: 3
Current progress of pig models for liver cancer research
Luyao Wang, Yuexian Piao, Fucheng Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115256-115256
Open Access | Times Cited: 6
Luyao Wang, Yuexian Piao, Fucheng Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115256-115256
Open Access | Times Cited: 6
Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
Ji Hong Kim, Young Il Kim, Heechul Nam, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
Ji Hong Kim, Young Il Kim, Heechul Nam, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access | Times Cited: 1
Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
Saikang Tang, Yingming Gao, Xue Yan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Saikang Tang, Yingming Gao, Xue Yan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Dynamic peripheral T-cell analysis identifies on-treatment prognostic biomarkers of atezolizumab plus bevacizumab in hepatocellular carcinoma
Ji Won Han, Min Woo Kang, Soon Kyu Lee, et al.
Liver Cancer (2024), pp. 1-13
Open Access | Times Cited: 1
Ji Won Han, Min Woo Kang, Soon Kyu Lee, et al.
Liver Cancer (2024), pp. 1-13
Open Access | Times Cited: 1
Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma
Nan Yi, Lingyun Zhang, Xiangbo Huang, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 1
Nan Yi, Lingyun Zhang, Xiangbo Huang, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 1
The interdisciplinary approach to investigate bona fide agent(s) in flavonoids or alkaloids in treating HCC
Ki‐Kwang Oh, Sang‐Jun Yoon, Seol Hee Song, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 500-511
Open Access
Ki‐Kwang Oh, Sang‐Jun Yoon, Seol Hee Song, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 500-511
Open Access
DysUFMylation of SREBP1 promotes the progression of hepatocellular carcinoma by reprogramming lipid metabolism
Yong Yi, Gao X, Min Xu, et al.
Research Square (Research Square) (2024)
Open Access
Yong Yi, Gao X, Min Xu, et al.
Research Square (Research Square) (2024)
Open Access
The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
Beom Kyung Kim
Gut and Liver (2024) Vol. 18, Iss. 1, pp. 3-4
Open Access
Beom Kyung Kim
Gut and Liver (2024) Vol. 18, Iss. 1, pp. 3-4
Open Access
Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
